怀孕的决定因素和子宫内膜异位症妇女的不良妊娠结果:一项纵向研究
Hrishikesh Munshi1, Tabassum Khan1, Shagufta Khan1
1Clinical Research Laboratory, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai, India.
Reproductive sciences (Thousand Oaks, Calif.)
|April 23, 2024
概括
这项关于印度子宫内膜异位症的研究发现,19.1%的女性怀孕. 淋病与怀孕有关,突显了对子宫内膜异位症患者更好的生育管理策略的需要.
科学领域:
- 生殖医学 生殖医学
- 妇科 妇科 妇科 妇科
- 流行病学 流行病学
背景情况:
- 子宫内膜异位症影响全球10%的女性,导致疼痛和不孕.
- 在像印度这样的低收入和中等收入国家,获得负担得起的不孕症护理是一个挑战.
- 了解子宫内膜异位症对生育能力的影响对于有效管理至关重要.
研究的目的:
- 调查印度子宫内膜异位症妇女的自然受孕和怀孕结果.
- 为了确定影响这一群体怀孕率的因素.
- 为改善生育管理策略提供见解.
主要方法:
- 一项多中心前性队列研究,涉及257名患有子宫内膜异位症的妇女,涉及6家印度三级医院 (2017-2022年).
- 收集关于怀孕率,怀孕结果和相关症状的数据.
- 统计分析以确定临床因素与受孕之间的相关性.
主要成果:
- 19.1%的参与者怀孕了,地理位置和收入差异很大.
- 经期不良 (疼痛的经期) 和经期不良 (疼痛的性交) 与受孕相关.
- 自然受孕发生在70%的病例中;活产率为85.7%.
- 这些并发症包括胎盘前期 (16.4%),妊娠前期 (4.1%) 和早产 (4.1%).
结论:
- 子宫内膜异位症显著影响印度妇女的受孕和怀孕结果.
- 淋病是与受孕困难相关的关键因素.
- 建议进行进一步的大规模多中心研究,以全面了解和改进印度不孕症管理策略.
更多相关视频
06:49Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
Published on: April 7, 2023
1.7K
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
15.9K
相关概念视频
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Infertility in Females
292
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
292
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Disorders of the Female Reproductive System
357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357
Spermatogenesis
102.4K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.4K
Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
